Outcomes Of Minimally Invasive Tricuspid Valve Surgery
Walid Abukhudair, Bayan Alshaikh.
KFAFH, jeddah, Saudi Arabia.
BACKGROUND: Our aim was to evaluate our 11 years experience on minimally invasive tricuspid valve (MITV) surgery alone or in combination with mitral valve (MV) surgery or atrial septal defect (ASD) repair . METHODS: Between January 2005 until November 2016, a total of 141 patients with tricuspid valve regurgitation (TR) ± concomitant MV surgery or ASD repair underwent MITV surgery at King Fahad Armed Forces Hospital (KFAFH). The mean age was 48 ±10.0 years, mean LVEF was 55%±10 % and 50 patients (35%) were male. The Average logistic EuroSCORE was 6.3%±3.2%, and patients had an average follow-up of 36± 12 months . 92.9% (131) had concomitant surgery 85.8% (121) had concomitant MV surgery and 7%(10) had concomitant ASD repair . RESULTS: Intra-operatively patient had a mean bypass time 189 ± 50 min , cross clamp time 85 ± 40 min and conversion to sternotomy 7% 1 patients . Overall 30-day mortality was 1.4% we had two mortalities . Pre-discharge echocardiography revealed no residual or only mild tricuspid regurgitation (TR) in 95.7% . 4 years follow up showed no residual or mild tricuspid regurgitation (TR) in 91.4% , freedom from TV-related reoperation was 97.1% and survival was 92.9%±2.5% CONCLUSIONS:Our experience shows that MITV surgery alone or in combination with other procedure can be performed routinely with good short and midterm operative results. We recommend that MITV should be considered for all patients undergoing TV surgery unless contraindications are present .
Back to 2018 ePosters